Related Experiment Video
Updated: Jun 24, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Clinical implications of patent foramen ovale in migraine with aura
Pasquale Marchione1, Natascia Ghiotto, Grazia Sances
1Neurovascular Unit, Department of Neurology and Otorhinolaringology, University La Sapienza, Rome, Italy.
Abstract:
The high incidence of patent foramen ovale (PFO) in migraine with aura (MWA) is well known. In this study we evaluated the relationship between PFO and aura features, and the relative impact of this association on stroke risk. We recruited patients with a diagnosis of MWA. PFO was assessed by contrast transcranial Doppler and confirmed by transoesophageal echocardiography. The 65 patients enrolled were divided into two groups on the basis of the clinical features of their aura: typical in 63.1% (Group 1) and atypical in 36.9% (Group 2). A statistically significant difference was found in PFO prevalence between the two groups (46.3% in Group 1 and 79.2% in Group 2; p=0.009). We did not observe any statistical difference between the two groups in the prevalence of classic stroke risk factors or in the profile of the thrombophilic markers. Our results underline the need to look for PFO particularly in subjects with atypical features of aura, but the underlying pathophysiology of the association is not clear.
Insights
Patent foramen ovale (PFO) is more common in migraine with aura (MWA) patients, especially those with atypical aura features. This finding suggests PFO screening may be beneficial for MWA patients with unusual symptoms.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- Patent foramen ovale (PFO) is frequently observed in patients experiencing migraine with aura (MWA).
- The specific relationship between PFO and the characteristics of aura symptoms, as well as its impact on stroke risk, requires further investigation.
Purpose of the Study:
- To investigate the association between patent foramen ovale (PFO) and the specific features of aura in patients diagnosed with migraine with aura (MWA).
- To assess the relative impact of the PFO-MWA association on stroke risk.
Main Methods:
- Patients diagnosed with MWA were enrolled and assessed for PFO using contrast transcranial Doppler and transoesophageal echocardiography.
- Participants were categorized into two groups based on aura characteristics: typical (Group 1) and atypical (Group 2).
Main Results:
- A significantly higher prevalence of PFO was observed in patients with atypical aura features (79.2%) compared to those with typical aura features (46.3%) (p=0.009).
- No significant differences were found in the prevalence of traditional stroke risk factors or thrombophilic markers between the groups.
Conclusions:
- The study highlights the importance of screening for PFO in MWA patients, particularly those presenting with atypical aura symptoms.
- The underlying pathophysiological mechanisms connecting PFO and atypical aura features remain unclear and warrant further research.
Related Concept Videos
Increased Intracranial Pressure ll: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cerebral Edema ll: Pathophysiology
Increased Intracranial Pressure l: Introduction
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
